Treatment of facial myokymia in multiple sclerosis with botulinum toxin

被引：5
作者：
Habek, Mario [1 ]
Adamec, Ivan
Gabelic, Tereza
Brinar, Vesna V.
机构：
[1] Zagreb Sch Med, Univ Dept Neurol, Referral Ctr Demyelinating Dis Cent Nervous Syst, Zagreb 10000, Croatia
来源：
ACTA NEUROLOGICA BELGICA | 2012年 / 112卷 / 04期
关键词：
Myokymia; Botulinum toxin; Multiple sclerosis;
D O I：
10.1007/s13760-012-0092-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：423 / 424
页数：2
相关论文
共 5 条
  • [1] Myokymia and neuromyotonia 2004
    Gutmann, L
    Gutmann, L
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 (02) : 138 - 142
  • [2] The place of the botulinum toxin in the management of multiple sclerosis
    Habek, Mario
    Karni, Arnon
    Balash, Yakov
    Gurevich, Tanya
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2010, 112 (07) : 592 - 596
  • [3] Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction
    Lew, MF
    [J]. CLINICAL JOURNAL OF PAIN, 2002, 18 (06) : S142 - S146
  • [4] Continuous facial myokymia in multiple sclerosis:: Treatment with botulinum toxin
    Sedano, MJ
    Trejo, JM
    Macarrón, JL
    Polo, JM
    Berciano, J
    Calleja, J
    [J]. EUROPEAN NEUROLOGY, 2000, 43 (03) : 137 - 140
  • [5] Facial myokymia associated with an isolated lesion of the facial nucleus
    Yoritaka, A
    Tsukamoto, T
    Ohta, K
    Kishida, S
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2001, 104 (03): : 182 - 184
1